SCOTIABANK GBM Maintains Dye & Durham (DYNDF) Outperform Recommendation

Scotiabank GBM maintained an Outperform on Dye & Durham (OTCPK:DYNDF) on Dec. 9, 2025, but the analyst consensus one‑year price target as of Dec. 6 is $6.39 (range $3.43–$11.50), implying a 32.64% downside to the last close of $9.49. The company is projected to generate $524M in annual revenue (up 11.61%) with non‑GAAP EPS of $0.47; institutional ownership is held by 31 funds (down five owners quarter‑over‑quarter), total institutional shares are roughly 6.215M (down 0.11%), while average portfolio weight has risen to 0.05% (up 30.07%). Major holders such as Fidelity’s Canada funds increased positions (FCNSX 4.635M shares, 6.90% stake; FICDX 822K shares), producing mixed fund sentiment that, together with the wide dispersion in price targets, signals valuation risk despite the Outperform rating.

Analysis

Scotiabank GBM maintained an Outperform on Dye & Durham on December 9, 2025, while the average one‑year analyst price target as of December 6 is $6.39 (range $3.43–$11.50), implying a 32.64% downside to the last close of $9.49. The wide dispersion of targets and the implied downside highlight a meaningful disconnect between the bank’s positive rating and broader analyst consensus.

Company fundamentals in the report show projected annual revenue of $524 million (up 11.61%) and projected non‑GAAP EPS of $0.47, which support growth but reflect modest near‑term profitability versus the current share price. Institutional positioning is mixed: 31 funds hold positions (down five owners, -13.89% q/q), total institutional shares sit at 6,215K (down 0.11%), yet average portfolio weight rose 30.07%, with Fidelity’s Canada funds representing the largest concentrated holdings (FCNSX 4,635K shares, ~6.90% ownership).

The primary near‑term risk is valuation uncertainty rather than business performance alone given the target range and mixed fund flows; absent clearer catalysts or analyst target revisions, expect potential downside or volatility. Key monitoring points are analyst revisions, actual revenue/EPS versus the $524M/0.47 projections, and activity by large holders such as Fidelity for directional conviction.

Key Decisions for Investors

• Given the consensus target implies ~32.6% downside despite an Outperform, avoid initiating large new long positions at the current $9.49 price and wait for analyst target upgrades or a clear operational catalyst
• If already long, consider trimming exposure or implementing hedges (e.g., protective puts) because of the wide price‑target dispersion ($3.43–$11.50) and modest projected non‑GAAP EPS of $0.47
• Monitor upcoming earnings/guidance for revenue and EPS versus the $524M/0.47 projections and watch institutional movements—particularly Fidelity’s sizeable stake—for signs to add exposure on confirmed positive revisions